A viral infection can reduce expression of a host phosphatase that would otherwise dampen the oncogenic activity of a bacterial virulence factor. The results suggest a possible mechanism for cooperation of infections in the development of stomach cancer.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
In vivo activation of pH-responsive oxidase-like graphitic nanozymes for selective killing of Helicobacter pylori
Nature Communications Open Access 31 March 2021
-
miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models
Scientific Reports Open Access 02 August 2017
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Saju, P. et al. Nature Microbiol. 1, 16026 (2016).
Ekstrom, A. M. et al. Gastroenterology 121, 784–791 (2001).
Hatakeyama, M. Cell Host Microbe 15, 306–316 (2014)
Bass, A. J. et al. Nature 513, 202–209 (2014).
Qiu, J. et al. PLoS Pathogens 11, e1004561 (2015).
Saha, A. et al. Proc. Natl Acad. Sci. USA 112, e5199–e5207 (2015).
Hansen, K. D. et al. Genome Res. 24, 177–184 (2014).
Matsusaka, K. et al. Cancer Res. 71, 7187–7197 (2011).
Lin, Z. et al. J. Virol. 90, 3469–3479 (2016).
Tsang, C. M. et al. Proc. Natl Acad. Sci. USA 109, e3473–e3482 (2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farrell, P. Pathogenesis: Infections causing gastric cancer. Nat Microbiol 1, 16038 (2016). https://doi.org/10.1038/nmicrobiol.2016.38
Published:
DOI: https://doi.org/10.1038/nmicrobiol.2016.38
This article is cited by
-
In vivo activation of pH-responsive oxidase-like graphitic nanozymes for selective killing of Helicobacter pylori
Nature Communications (2021)
-
miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models
Scientific Reports (2017)